SCHEMBL26014633

SCHEMBL26014633

CC(C)Cc1cccc(C(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.44
HTR2A P28223 3/20 0.42
HTR2B P41595 2/20 0.42
HTR2C P28335 1/20 0.42
GABRA1 P14867 2/20 0.41
GABRB2 P47870 2/20 0.41
PNMT P11086 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.40
PGK1 P00558 1/20 0.40
PGK2 P07205 1/20 0.40
TAAR1 Q96RJ0 4/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
MAOA P21397 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CYP2A6 P11509 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11789845 0.85 HDAC4 (0.42) HTR2AHTR2BHTR2CGABRA1GABRB2
SCHEMBL8539519 0.82 GABRA1 (0.50) HTR2AHTR2BHTR2CGABRA1GABRB2
SCHEMBL8792716 0.82 GABRA1 (0.40) HTR2AHTR2BHTR2CGABRA1GABRB2
SCHEMBL19557961 0.82 GABRA1 (0.44) HTR2AHTR2BGABRA1GABRB2PNMT
SCHEMBL8792217 0.82 PNMT (0.44) HTR2AHTR2BHTR2CGABRA1GABRB2
SCHEMBL28486515 0.82 GABRA1 (0.40) HTR2AHTR2BHTR2CGABRA1GABRB2
SCHEMBL8793457 0.82 GABRA1 (0.44) HTR2AHTR2BGABRA1GABRB2PNMT
SCHEMBL8792478 0.82 MEN1 (0.47) HTR2AHTR2BGABRA1GABRB2PNMT
SCHEMBL29967289 0.82 MEN1 (0.47) HTR2AHTR2BGABRA1GABRB2PNMT
SCHEMBL9336482 0.82 GABRA1 (0.40) HTR2AGABRA1GABRB2PNMTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154291-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed